Nanoform Capacity Update February 2024: Small Molecule

Source: Nanoform

The presentation from the February 2024 OPCU event introduces Nanoform, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients. Case studies will show how nanoparticles can enable faster onset of oral medications, reduce initial burst, extend the therapeutic window of long-acting implants, and increase drug loading in hydrogel formulations. Bioequivalence of a nanocrystalline formulation with an amorphous dispersion, and an ongoing clinical study will also be announced. Delve into Nanoform’s manufacturing capabilities, including ongoing and planned GMP expansion for highly-potent APIs.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma